Characterization and Clinical Trial of an Innovative High-Speed Lancing Device
An innovative high-speed lancing device has a lancet that moves so fast that it is not affected at all by the vibration of its spring, and does not pierce the skin repeatedly, greatly reducing the pain that is caused to diabetes mellitus (DM) patients during blood sampling. As revealed by experiment...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-04-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3417/6/4/111 |
_version_ | 1817992447870894080 |
---|---|
author | Ho Chang Yao-Jen Yeh Rahnfong Lee Chia-Chun Lee Jenq-Huey Shyu |
author_facet | Ho Chang Yao-Jen Yeh Rahnfong Lee Chia-Chun Lee Jenq-Huey Shyu |
author_sort | Ho Chang |
collection | DOAJ |
description | An innovative high-speed lancing device has a lancet that moves so fast that it is not affected at all by the vibration of its spring, and does not pierce the skin repeatedly, greatly reducing the pain that is caused to diabetes mellitus (DM) patients during blood sampling. As revealed by experimental measurements of the acceleration of a lancet using an accelerometer, the lancet pierces the skin only once. The maximum acceleration and the instant piercing velocity of the lancet are 9.4 times and 1.78 times those of a conventional lancing device, respectively. Meanwhile, the period for which the lancet remains in the skin is 0.014 s shorter than that of the conventional lancing device. A clinical trial that involved 100 participants yielded statistical results concerning the numeric rating of pain scale (NRS) of pain intensity, which is internationally recognized as the pain with the highest validity, that showed that the NRS of participants who used the innovative high-speed lancing device was 2.65 less than that of those who used the conventional lancing device, and the duration of the pain after blood sampling was 76.1 min shorter. |
first_indexed | 2024-04-14T01:26:31Z |
format | Article |
id | doaj.art-9f61f43c1fda4aa8ae955f5a2f370fcd |
institution | Directory Open Access Journal |
issn | 2076-3417 |
language | English |
last_indexed | 2024-04-14T01:26:31Z |
publishDate | 2016-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Applied Sciences |
spelling | doaj.art-9f61f43c1fda4aa8ae955f5a2f370fcd2022-12-22T02:20:25ZengMDPI AGApplied Sciences2076-34172016-04-016411110.3390/app6040111app6040111Characterization and Clinical Trial of an Innovative High-Speed Lancing DeviceHo Chang0Yao-Jen Yeh1Rahnfong Lee2Chia-Chun Lee3Jenq-Huey Shyu4Graduate Institute of Manufacturing Technology, National Taipei University of Technology, Taipei 10608, TaiwanGraduate Institute of Mechanical and electrical Engineering, National Taipei University of Technology, Taipei 10608, TaiwanJoinsoon Medical Technology Co., Ltd., New Taipei City 221, TaiwanGraduate Institute of Mechanical and electrical Engineering, National Taipei University of Technology, Taipei 10608, TaiwanGraduate Institute of Mechanical and electrical Engineering, National Taipei University of Technology, Taipei 10608, TaiwanAn innovative high-speed lancing device has a lancet that moves so fast that it is not affected at all by the vibration of its spring, and does not pierce the skin repeatedly, greatly reducing the pain that is caused to diabetes mellitus (DM) patients during blood sampling. As revealed by experimental measurements of the acceleration of a lancet using an accelerometer, the lancet pierces the skin only once. The maximum acceleration and the instant piercing velocity of the lancet are 9.4 times and 1.78 times those of a conventional lancing device, respectively. Meanwhile, the period for which the lancet remains in the skin is 0.014 s shorter than that of the conventional lancing device. A clinical trial that involved 100 participants yielded statistical results concerning the numeric rating of pain scale (NRS) of pain intensity, which is internationally recognized as the pain with the highest validity, that showed that the NRS of participants who used the innovative high-speed lancing device was 2.65 less than that of those who used the conventional lancing device, and the duration of the pain after blood sampling was 76.1 min shorter.http://www.mdpi.com/2076-3417/6/4/111lancing deviceself-monitoring of blood glucose (SMBG)accelerometernumeric rating scale (NRS) |
spellingShingle | Ho Chang Yao-Jen Yeh Rahnfong Lee Chia-Chun Lee Jenq-Huey Shyu Characterization and Clinical Trial of an Innovative High-Speed Lancing Device Applied Sciences lancing device self-monitoring of blood glucose (SMBG) accelerometer numeric rating scale (NRS) |
title | Characterization and Clinical Trial of an Innovative High-Speed Lancing Device |
title_full | Characterization and Clinical Trial of an Innovative High-Speed Lancing Device |
title_fullStr | Characterization and Clinical Trial of an Innovative High-Speed Lancing Device |
title_full_unstemmed | Characterization and Clinical Trial of an Innovative High-Speed Lancing Device |
title_short | Characterization and Clinical Trial of an Innovative High-Speed Lancing Device |
title_sort | characterization and clinical trial of an innovative high speed lancing device |
topic | lancing device self-monitoring of blood glucose (SMBG) accelerometer numeric rating scale (NRS) |
url | http://www.mdpi.com/2076-3417/6/4/111 |
work_keys_str_mv | AT hochang characterizationandclinicaltrialofaninnovativehighspeedlancingdevice AT yaojenyeh characterizationandclinicaltrialofaninnovativehighspeedlancingdevice AT rahnfonglee characterizationandclinicaltrialofaninnovativehighspeedlancingdevice AT chiachunlee characterizationandclinicaltrialofaninnovativehighspeedlancingdevice AT jenqhueyshyu characterizationandclinicaltrialofaninnovativehighspeedlancingdevice |